Quantum Biopharma Ltd. Files 6-K, Formerly FSD Pharma Inc.
Ticker: QNTM · Form: 6-K · Filed: Mar 28, 2025 · CIK: 1771885
| Field | Detail |
|---|---|
| Company | Quantum Biopharma Ltd. (QNTM) |
| Form Type | 6-K |
| Filed Date | Mar 28, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: reporting, foreign-private-issuer, company-name-change
TL;DR
Quantum Biopharma (fka FSD Pharma) filed a 6-K on 3/28/25, confirming 20-F reporting.
AI Summary
Quantum Biopharma Ltd. filed a Form 6-K on March 28, 2025, reporting as a foreign private issuer. The company, formerly known as FSD Pharma Inc. until March 27, 2019, is based in Toronto, Canada, and operates in the Pharmaceutical Preparations sector. This filing indicates they will file annual reports under Form 20-F.
Why It Matters
This filing confirms Quantum Biopharma's status as a foreign private issuer and its reporting obligations with the SEC, providing transparency for investors.
Risk Assessment
Risk Level: low — This is a routine filing for a foreign private issuer and does not contain new financial or operational information that would inherently increase risk.
Key Players & Entities
- Quantum Biopharma Ltd. (company) — Registrant
- FSD Pharma Inc. (company) — Former company name
- March 28, 2025 (date) — Filing date
- March 27, 2019 (date) — Date of name change
- Toronto, Canada (location) — Company headquarters
- Form 6-K (document) — Filing type
- Form 20-F (document) — Annual report filing type
FAQ
What is the primary purpose of this Form 6-K filing?
The Form 6-K is a report of a foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, for the month of March 2025.
What was Quantum Biopharma Ltd. previously known as?
Quantum Biopharma Ltd. was formerly known as FSD Pharma Inc., with a date of name change on March 27, 2019.
Where is Quantum Biopharma Ltd. headquartered?
The company's principal executive office is located at 55 University Ave., Suite 1003, Toronto, Ontario, M5J2H7, Canada.
Which SEC form does Quantum Biopharma Ltd. indicate it will file annual reports under?
Quantum Biopharma Ltd. indicates it will file annual reports under cover of Form 20-F.
What is the SIC code for Quantum Biopharma Ltd.?
The Standard Industrial Classification (SIC) code for Quantum Biopharma Ltd. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on March 28, 2025 regarding Quantum Biopharma Ltd. (QNTM).